DR_SEQAN:: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes

被引:11
|
作者
Garriga, C [1 ]
Menéndez-Arias, L [1 ]
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
关键词
D O I
10.1186/1471-2334-6-44
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Genotypic assays based on DNA sequencing of part or the whole reverse transcriptase (RT)- and protease (PR)-coding regions of the human immunodeficiency virus type 1 (HIV-1) genome have become part of the routine clinical management of HIV-infected individuals. However, the results are difficult to interpret due to complex interactions between mutations found in viral genes. Results: DR_SEQAN is a tool to analyze RT and PR sequences. The program output includes a list containing all of the amino acid changes found in the query sequence in comparison with the sequence of a wild-type HIV-1 strain. Translation of codons containing nucleotide mixtures can result in potential ambiguities or heterogeneities in the amino acid sequence. The program identifies all possible combinations of 2 or 3 amino acids that derive from translation of triplets containing nucleotide mixtures. In addition, when ambiguities affect codons relevant for drug resistance, DR_SEQAN allows the user to select the appropriate mutation to be considered by the program's drug resistance interpretation algorithm. Resistance is predicted using a rule-based algorithm, whose efficiency and accuracy has been tested with a large set of drug susceptibility data. Drug resistance predictions given by DR_SEQAN were consistent with phenotypic data and coherent with predictions provided by other publicly available algorithms. In addition, the program output provides two tables showing published drug susceptibility data and references for mutations and combinations of mutations found in the analyzed sequence. These data are retrieved from an integrated relational database, implemented in Microsoft Access, which includes two sets of non-redundant core tables (one for combinations of mutations in the PR and the other for combinations in the RT). Conclusion: DR_SEQAN is an easy to use off-line application that provides expert advice on HIV genotypic resistance interpretation. It is coded in Visual Basic for use in PC/Windows-based platforms. The program is freely available under the General Public License. The program (including the integrated database), documentation and a sample sequence can be downloaded from http://www2.cbm.uam.es:8080/Imenendez/DR_SEQAN.zip
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes
    Burdorf, Rachel M.
    Zhou, Shuntai
    Amon, Claire
    Long, Nathan
    Hill, Collin S.
    Adams, Lily
    Tegha, Gerald
    Chagomerana, Maganizo B.
    Jumbe, Allan
    Maliwichi, Madalitso
    Wallie, Shaphil
    Li, Yijia
    Swanstrom, Ronald
    Hosseinipour, Mina C.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (01): : 86 - 94
  • [42] Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1
    Althaus, CL
    Bonhoeffer, S
    JOURNAL OF VIROLOGY, 2005, 79 (21) : 13572 - 13578
  • [43] Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan
    Chang, Sui-Yuan
    Chen, Mao-Yuan
    Lee, Chun-Nan
    Sun, Hsin-Yun
    Ko, Wilson
    Chang, Shu-Fang
    Chang, Kei-Lung
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Liu, Wen-Chun
    Wu, Cheng-Hsin
    Kao, Chuan-Liang
    Hung, Chien-Ching
    Chang, Shan-Chwen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 689 - 693
  • [44] Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes
    Quercia, Romina
    Dam, Elisabeth
    Perez-Bercoff, Danielle
    Clavel, Francois
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 10245 - 10249
  • [45] Substrate envelope and drug resistance: Crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease
    Prabu-Jeyabalan, M
    King, NM
    Nalivaika, EA
    Heilek-Snyder, G
    Cammack, N
    Schiffer, CA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) : 1518 - 1521
  • [46] A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1
    Garcia-Perez, J.
    Sanchez-Palomino, S.
    Perez-Olmeda, M.
    Fernandez, B.
    Alcami, J.
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (02) : 127 - 137
  • [47] Drug Resistance in Human Immunodeficiency Virus Type-1 Infected Zambian Children Using Adult Fixed Dose Combination Stavudine, Lamivudine, and Nevirapine
    Gupta, Ravindra K.
    Ford, Deborah
    Mulenga, Veronica
    Walker, A. Sarah
    Kabamba, Desire
    Kalumbi, Moxmalama
    Grant, Paul R.
    Ferrier, Alexander
    Pillay, Deenan
    Gibb, Diana M.
    Chintu, Chifumbe
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (08) : E57 - E62
  • [48] Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review
    Nurjannah
    Jayanti, Sri
    Tanoerahardjo, Francisca Srioetami
    Al Musyahadah, Ummu Syauqah
    Sukowati, Caecilia Hapsari Ceriapuri
    Massi, Muhammad Nasrum
    CURRENT HIV/AIDS REPORTS, 2024, 21 (02) : 31 - 39
  • [49] Prevalence of Drug Resistance in Human Immunodeficiency Virus Type 1-Infected Treatment-Naive Children in Pune, India
    Kumar, Mukesh
    Sen, Sourav
    Gupta, Rakesh K.
    Chaturbhuj, Devidas
    Tripathy, Srikanth P.
    Paranjape, Ramesh S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (03) : 294 - 298
  • [50] INTERACTIONS BETWEEN DRUG-RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    LARDER, BA
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 951 - 957